Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease

Figure 5

There were no significant differences between the ≥10³ copies/mL group and the <10³ copies/mL group in baseline anti-HBs titer, titer at successful establishment of immunity, the highest titer after vaccination, the lowest titer before booster vaccination, the highest titer after boost vaccination, titer when HBIG was withdrawn, and the titer at the end of followup (vacc.: vaccination).